1. Home
  2. KSCP vs EVAX Comparison

KSCP vs EVAX Comparison

Compare KSCP & EVAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Knightscope Inc.

KSCP

Knightscope Inc.

HOLD

Current Price

$1.23

Market Cap

35.9M

ML Signal

HOLD

Logo Evaxion Biotech

EVAX

Evaxion Biotech

N/A

Current Price

$3.04

Market Cap

29.7M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
KSCP
EVAX
Founded
2013
2008
Country
United States
Denmark
Employees
N/A
N/A
Industry
Telecommunications Equipment
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Telecommunications
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
35.9M
29.7M
IPO Year
2022
2020

Fundamental Metrics

Financial Performance
Metric
KSCP
EVAX
Price
$1.23
$3.04
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
3
3
Target Price
$17.00
$11.67
AVG Volume (30 Days)
603.6K
229.8K
Earning Date
05-12-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
63.54
N/A
EPS
N/A
N/A
Revenue
$11,335,000.00
N/A
Revenue This Year
$218.66
N/A
Revenue Next Year
$54.32
$328.20
P/E Ratio
N/A
N/A
Revenue Growth
4.91
N/A
52 Week Low
$1.32
$2.77
52 Week High
$7.62
$12.15

Technical Indicators

Market Signals
Indicator
KSCP
EVAX
Relative Strength Index (RSI) 41.49 46.68
Support Level N/A $3.02
Resistance Level $1.52 $3.62
Average True Range (ATR) 0.07 0.15
MACD 0.01 -0.01
Stochastic Oscillator 10.26 31.84

Price Performance

Historical Comparison
KSCP
EVAX

About KSCP Knightscope Inc.

Knightscope Inc is a security technology company based in Silicon Valley. It designs, develops, manufactures, markets, and supports Autonomous Security Robots (ASRs), autonomous charging stations, the proprietary Knightscope Security Operations Center software user interface, Emergency Communication Devices platform with real-time on-site data collection and analysis and a proprietary interface for both indoor and outdoor usage. In addition, it developed and operates the Knightscope Security Operations Center (KSOC) which allows real-time data access, a service accessible to all its clients.

About EVAX Evaxion Biotech

Evaxion AS is a clinical-stage TechBio company developing novel vaccines with its proprietary, clinically validated and scalable AI platform, AI-Immunology. The platform harnesses the power of artificial intelligence to decode the human immune system and develop novel vaccine candidates for cancer and infectious diseases for patients in the market. Evaxion has developed a clinical-stage oncology pipeline of novel personalised vaccines and a preclinical infectious disease pipeline in bacterial and viral diseases with high unmet medical needs. The group is committed to transforming patients' lives by providing inventive and targeted treatment options.

Share on Social Networks: